HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

Emergency room visits after abortion-drug use were 79 percent more likely to be miscoded as natural miscarriages compared with those following surgical abortions, according to a new study ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. “As with all drugs, FDA continues to ...

US HHS Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions.

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner ...